Trust Point Inc’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$665K Sell
9,411
-3,927
-29% -$212K 0.06% 177
2026
Q1
$697K Sell
13,338
-87
-0.6% -$5.22K 0.06% 174
2025
Q4
$790K Buy
13,425
+271
+2% +$16.5K 0.06% 155
2025
Q3
$732K Buy
13,154
+1,104
+9% +$59.1K 0.06% 157
2025
Q2
$620K Sell
12,050
-3,208
-21% -$161K 0.06% 150
2025
Q1
$895K Sell
15,258
-780
-5% -$52.9K 0.08% 126
2024
Q4
$1.16M Buy
16,038
+7,333
+84% +$538K 0.08% 133
2024
Q3
$696K Buy
8,705
+326
+4% +$24.5K 0.05% 222
2024
Q2
$600K Buy
8,379
+237
+3% +$17.4K 0.05% 240
2024
Q1
$573K Buy
8,142
+55
+0.7% +$3.94K 0.05% 259
2023
Q4
$624K Buy
+8,087
New +$533K 0.05% 226

Other funds holding TECH

Trust Point Inc's TECH Position: Q2 2026 in Review

Trust Point Inc reduced its Bio-Techne (TECH) stake by 29% in Q2 2026, selling an estimated $212K and leaving 9,411 shares worth $665K. The position accounts for 0.06% of the portfolio, ranked #177.

Trust Point Inc first reported a position in TECH in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.16M in Q4 2024. 91 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Trust Point Inc held 9,411 shares of Bio-Techne worth $665K as of Q2 2026.
  • Trust Point Inc sold 3,927 Bio-Techne shares in Q2 2026, an estimated $212K.
  • Bio-Techne made up 0.06% of Trust Point Inc's portfolio in Q2 2026, its #177 holding.
  • Trust Point Inc first reported a position in Bio-Techne in Q4 2023 and has held it in 11 quarters since.
  • Trust Point Inc's Bio-Techne position peaked at $1.16M in Q4 2024.
  • 91 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Trust Point Inc's 13F filing for Q2 2026, filed 8 Jul 2026.